RT journal article
T1 Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphinenaloxone
A1 Pérez de los Cobos, José
A1 Alcaraz, Saul
A1 Siñol, Núria
A1 González Saiz, Francisco Manuel
A1 Vergara Moragues, Esperanza
A1 Trujols, Joan
A1 Buprenorphine/Naloxone Survey
A2 Neurociencias
A2 Psicología
K1 patient satisfaction
K1 opioid
K1 factor structure
K1 replicability
K1 methadone
K1 buprenorphine-naloxone
AB Background: Patient satisfaction with methadone or buprenorphine-naloxone can be multidimensionally and specifically assessed by using, respectively, the Scale to Assess Satisfaction with Medications for Addiction Treatment–Methadone for Heroin addiction (SASMAT-METHER) or the SASMAT–Buprenorphine-Naloxone for Heroin addiction (SASMAT-BUNHER). The factor structures of the SASMAT-METHER and SASMAT-BUNHER show substantial commonalities. The objective of the present study is to evaluate the replicability of the SASMAT-METHER factor structure using data from the SASMAT-BUNHER development study in order to obtain an instrument that can be used to compare patient satisfaction with methadone vs. buprenorphine-naloxone. Method: Secondary analysis of SASMAT-BUNHER data provided by 205 participants in the original validation study of that scale (Pérez de los Cobos et al., 2018). Using the SASMAT-METHER component solution (17 items, 3 factors) as the target structure, a principal component analysis was performed on the data set comprised of thecorresponding 17 SASMAT-BUNHER items using an oblique semi-specified Procrustean rotation. Additionally, Tucker congruence coefficients were computed to examine the correspondence between the two solutions. Result: The factor structures of SASMAT-METHER and the 17-item version of the SASMAT-BUNHER can be considered equal given that the overall Tucker’s congruence coefficient of factorial similarity was 0.972, with individual component congruencies ranging from 0.960 to 0.995.Conclusions: The SASMAT-METHER component solution can serve as a single common tool to comparemethadone vs. buprenorphine-naloxone in terms of patient satisfaction. This finding supports the feasibility of using a common metric to specifically assess satisfaction with medications to treat heroin dependence.
SN 0376-8716
YR 2020
FD 2020
LK http://hdl.handle.net/10498/33109
UL http://hdl.handle.net/10498/33109
LA eng
DS Repositorio Institucional de la Universidad de Cádiz
RD 10-may-2026